Progyny (PGNY) Invested Capital (2018 - 2026)

Progyny (PGNY) has 9 years of Invested Capital data on file, last reported at $439.3 million in Q1 2026.

• Quarterly Invested Capital fell 5.95% year-over-year to $439.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $439.3 million (down 5.95% YoY) and the FY2025 annual result came in at $516.0 million, up 22.27% from the prior year.
• Invested Capital retreated to $439.3 million in Q1 2026 per PGNY's latest filing, from $516.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $571.6 million in Q1 2024 and bottomed at $279.6 million in Q1 2022.
• The 5-year median for Invested Capital is $456.2 million (2024), against an average of $450.6 million.
• The widest annual swing landed in 2022, when Invested Capital surged 54.77%; it then retreated 23.74% in 2024.
• Tracing PGNY's Invested Capital over 5 years: stood at $377.0 million in 2022, then surged by 46.81% to $553.4 million in 2023, then dropped by 23.74% to $422.1 million in 2024, then gained by 22.27% to $516.0 million in 2025, then fell by 14.86% to $439.3 million in 2026.
• Per Business Quant, the three latest PGNY Invested Capital figures stand at $439.3 million (Q1 2026), $516.0 million (Q4 2025), and $560.0 million (Q3 2025).

Peer Comparison